Zurivogli 0.3mg Tablet
Marketer
Zurinovo Healthcare Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Zurivogli 0.3mg Tablet
Glycemia Control 0.3mg tablets are indicated for managing type 2 diabetes. This medication aids in post-prandial blood glucose regulation, employed when dietary modifications and other comparable treatments prove insufficient. Administer Glycemia Control 0.3mg just prior to meals; dosage and frequency are determined by your physician to optimize blood sugar control. Abrupt discontinuation is inadvisable without consulting your doctor, as this can elevate blood glucose, potentially resulting in serious complications such as renal impairment or vision loss. This medication is a component of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your physician. Regular blood glucose monitoring is essential while using this medication. Commonly reported adverse effects include gas, abdominal discomfort, decreased appetite, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Glycemia Control 0.3mg alone does not induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Glucose should be used to treat hypoglycemic episodes; sucrose or other common sugars are ineffective in this context. Inform your doctor of any liver or kidney conditions before initiating treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all medications currently being taken to ensure medication safety. Excessive alcohol consumption should be avoided during treatment, as it can heighten the risk of hypoglycemia.
Uses of Zurivogli 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Zurivogli 0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Zurivogli 0.3mg Tablet should be taken on an empty stomach.
Common Side effects of Zurivogli 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Zurivogli 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Zurivogli 0.3mg Tablet on an empty stomach.
How Zurivogli 0.3mg Tablet works:
Glucozym 0.3mg tablets are used to manage diabetes. They work by blocking the digestive enzymes that process complex carbohydrates, thus reducing the post-meal surge in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Zurivogli 0.3mg tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Zurivogli 0.3mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Based on limited available data from human studies, taking a 0.3mg Zurivogli tablet during breastfeeding is likely safe, posing minimal discernible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Zurivogli 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Zurivogli 0.3mg tablets. Dosage modification of Zurivogli 0.3mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.3mg Zurivogli tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Zurivogli 0.3mg Tablet :
Omit any missed Zurivogli 0.3mg Tablet dose and resume your regular medication schedule; avoid taking a double dose.
Facts to Know About Zurivogli 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
3,018 People bought this recently